Tulrampator Uses, Dosage, Side Effects and more
Tulrampator is under investigation in clinical trial NCT02626572 (Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms).
| Trade Name | Tulrampator |
| Generic | Tulrampator |
| Tulrampator Other Names | Tulrampator |
| Type | |
| Formula | C20H17FN4O3 |
| Weight | Average: 380.379 Monoisotopic: 380.128468586 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
